Transduced mesenchymal stem cells
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 7, 1997
Grant Date -
N/A
app pub date -
Nov 24, 1993
filing date -
Nov 24, 1993
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Genetically engineered human stem cells that carry within them genes of interest particularly for the expression of physiologically or pharmacologically active proteins or for use in gene therapy. In addition to correction of genetic disorders, is the ability to introduce, in a targeted manner, additional copies of essential genes to allow expression in proliferating, nondifferentiating cells of certain gene products. These genes can be, for example, hormones matrix proteins, cytokines, adhesion molecules, detoxification enzymes and 'rebuilding' proteins important in tissue repair.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully